What is Moovcare®?
A Class I medical device, Moovcare® has been proven in clinical trials to improve overall survival by 7.6 months
Improvement in overall survival +7.6
How early detection improves survival
CT scans can detect anomalies too late for doctors to treat effectively. Moovcare monitors and analyzes patient reported symptoms weekly for the first signs of trouble.
The moment an anomaly is detected, an alert is sent to the care team, enabling them to make an informed decision on whether and how to investigate the matter further.
Offer optimal treatment
By intervening as soon as possible, before the patient’s health deteriorates, the physician can offer the optimum treatment - thereby increasing the chances of survival and improving quality of life.
The right treatment at the right time
Standard lung cancer follow-up.Problem discovered weeks or months after event
Moovcare® lung cancer follow-up.Caregiver alerted the moment a problem is detected
How Moovcare® Works
Physician prescribes Moovcare® to patient
Patient reports symptoms weekly via web survey
Algorithm analyzes the symptoms
If an anomaly is detected, alert sent to medical team for further investigation
A new reality in lung cancer follow-up
The Moovcare® advantage
Improvement on standard follow-up
Frequency of follow-up
Weekly updates on the patient’s condition
Provides continuous clinical vision between scheduled visits and CTs
Proactive and dynamic
Adds agility to care in response to changing conditions
Earliest possible detection offers improved overall survival
Identify problems weeks and months earlier than before
Patient directly involved in monitoring their own health
Patient empowered, reassured through the active role they play
Reassured by constant communication with caregiver
Healthier state-of-mind, better qualityof life